Comparison of Wallstent and Ultraflex stents for palliation of malignant left-sided colon obstruction: a retrospective, case-matched analysis.
BACKGROUND
Self-expandable metal stents (SEMSs) are accepted palliation for malignant colon obstruction. Outcomes of different stent types is unknown.


OBJECTIVE
Our purpose was to compare outcomes after palliative placement of the Enteral Wallstent (EW) and the Precision Colonic Ultraflex (PCU) stent.


METHODS
Retrospective study of all SEMS placement during a 7-year period.


METHODS
Tertiary care academic medical center.


METHODS
Malignant left-sided colon obstruction in which through-the-scope (TTS) or non-TTS stent placement was possible.


METHODS
Technical and clinical success rates, stent-related complications, reintervention.


RESULTS
Demographics, degree, site, and cause of obstruction were comparable. Technical difficulties were more frequent with EW than PCU (16% vs 9%, P not significant), insufficient stent expansion and stent misplacement being most common. Relief of obstruction occurred in all patients when placement was technically successful. Mean follow-up was 93 days (range 7-691 days). Early (<7 days) stent occlusion (6% vs 0%, P not significant) and migration (4% vs 0%, P not significant) occurred more frequently in the EW group. Self-limited hematochezia was more common with PCU (20% vs 2%, P = .002). Delayed complications (perforation, stent occlusion, migration, and erosion) occurred significantly more often in the EW group (38% vs 20%). Reintervention was needed more frequently for EW, endoscopic (40% vs 17%, P = .01) and operative (46% vs 26%, P = .03).


CONCLUSIONS
Enteral Wallstents and Precision Ultraflex Colonic stents adequately relieve colonic obstruction. Stent dysfunction, stent-related complications, and need for reintervention are higher after EW placement. Precision Colonic Ultraflex stents appear better suited for palliation of left-sided malignant colon obstruction.
Small
Aaron J
AJ
Mayo Medical School, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Baron
Todd H
TH
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000473:pathology* / Q000628:therapy; D015331:Cohort Studies; D003108:Colonic Diseases / Q000209:etiology / Q000628:therapy*; D015179:Colorectal Neoplasms / Q000473:pathology* / Q000628:therapy; D004867:Equipment Design; D005260:Female; D006801:Humans; D007415:Intestinal Obstruction / Q000209:etiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D019919:Prosthesis Implantation; D012189:Retrospective Studies; D015607:Stents; D016896:Treatment Outcome